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Abstract
The demand for vaccination against infectious diseases involves a choice between vaccinating and not vaccinating, in which
there is a trade-off between the benefits and costs of each option. The aim of this paper is to investigate these trade-offs
and to estimate how the perceived prevalence and severity of both the disease against which the vaccine is given and any
vaccine associated adverse events (VAAE) might affect demand. A Discrete Choice Experiment (DCE) was used to elicit
stated preferences from a representative sample of 369 UK mothers of children below 5 years of age, for three hypothetical
vaccines. Cost was included as an attribute, which enabled estimation of the willingness to pay for different vaccines having
differing levels of the probability of occurrence and severity of both the infection and VAAE. The results suggest that the
severity of the health effects associated with both the diseases and VAAEs exert an important influence on the demand for
vaccination, whereas the probability of these events occurring was not a significant predictor. This has important
implications for public health policy, which has tended to focus on the probability of these health effects as the main
influence on decision making. Our results also suggest that anticipated regrets about the consequences of making the
wrong decision also exert an influence on demand.
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Introduction
Vaccination programmes have succeeded in reducing the
adverse health effects of many diseases. However, in recent years
people have become increasingly aware of the possible adverse
side effects of vaccines. Declining vaccine uptake rates have been
observed in many developed countries, leading to concern that
epidemics may re-emerge. Policy makers are therefore interested
in understanding the factors associated with acceptance of
vaccination. Understanding the determinants of demand can help
to improve predictions of vaccine uptake rates, identify effective
policy interventions to increase demand and facilitate the
economic evaluation of policy measures.
In choosing whether or not to vaccinate, people are affected by
perceived risks, by which we mean exposure to a factor that may
lead to impairment in their health. These risks comprise two
elements: the probability of an undesired outcome, impaired
health, and the magnitude of that outcome, the extent to which
health is impaired. Both of these elements are relevant to both of
the alternatives in a choice about vaccination – to vaccinate or not
to vaccinate. For example, there is a probability of disease if the
choice is to remain unvaccinated. A greater perceived probability
of infection is likely to have a positive effect on the demand for
vaccination against it. But there is also a probability of vaccine
associated adverse events (VAAE), which will have a negative
effect on vaccine demand. The nature of the overall risks may be
quite different for different common infectious diseases. The
probability of VAAE may be small, but the effects may be, or
perceived to be, severe and permanent. The probability of
infection if unvaccinated may be much higher, but the impact of
the resulting disease may be, or perceived to be, temporary and
minor.
Empirical analyses of the demand for vaccination have
generally relied on observed real-world choices in the light of
actual risks that were known by experts when those choices were
made [1]. However it is possible that the risks actually being
considered by people making these choices may differ from the
real risks, reflecting the fact that they may gather information from
various informal and formal sources of varying accuracy and
relevance. In such circumstances, stated preference techniques for
eliciting preferences have an advantage, since they allow the
investigation of variables that are not observable from real-world
data but may be influential in decision making.
This paper reports on a Discrete Choice Experiment (DCE)
undertaken to investigate these issues, based on choices by mothers
about three vaccines that might be given to their children. The
DCE method is based on the premise that how people value a good
or service can be evaluated by examining the nature and level of
the attributes that the good or service has [2–5].
Theoretical Considerations
Among the theories examining factors that contribute to
decisions to vaccinate the Health Belief model has been the most
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widely applied [6]. The Health Belief model proposes that the
decision to vaccinate is a function of perceived susceptibility to and
severity of disease as well as concern about vaccine benefits and
risks [7–10]. The perceived susceptibility to disease can be
described as the subjective perceived risk (or probability) of
contracting a disease [8]. The perceived severity of disease is the
subjective feeling concerning the seriousness of disease including
health and social consequences. The perception of benefit versus
costs is the evaluation of the effectiveness of alternative actions that
can be taken to reduce the disease threat [8]. The choice of
vaccination is a decision under uncertainty, and choice is guided
by balancing costs and benefits associated with vaccination versus
non-vaccination. Sadique et al [11] hypothesised that the per-
ceived relative risk of infection compared to that of VAAE has
a threshold below which a person will prefer to remain exposed to
the infectious disease and above which they will choose
vaccination. This provides an intuitively plausible explanation
for declining vaccine rates in developed countries. Vaccines have
largely eliminated the threat of many serious childhood diseases,
while concerns regarding alleged VAAE have increased. For many
people, the perceived relative risk has fallen below the threshold,
lowering the propensity to vaccinate.
This way of viewing vaccination decisions suggests the following
hypotheses. First, the higher the perceived risk of VAAE, the lower
the demand for vaccination is. Perceived risk is influenced by the
probability and severity of VAAE. Secondly, the higher the
perceived risk of infection is, influenced by the probability of
infection and the severity of health effects resulting from infection,
the higher the demand for vaccination is.
An obvious way to view the vaccination choice is that people
maximise their expected utility, so that they demand vaccination
when the expected gain from the lower risk of infection exceeds
the expected gain from not being exposed to VAAE. But what if
the choice is ex post wrong, in the sense that vaccination actually
leads to VAAE or non-vaccination leads to infection? The
possibility of ex post non-realisation of ex ante expectation can bring
a sense of loss, or regret, that may also be anticipated ex ante [12].
Regret is a negative, cognitively based emotion that we experience
when realising or imagining that our present situation would have
been better, had we acted differently [13]. Regret theory suggests
that decision-makers when making decisions under uncertainty
optimise the expected value of a ‘‘modified’’ utility where expected
utilities are modified by feelings of regret if things turn out worse
than they would have done under the other option, or by rejoicing
if things turn out better [12]. Using this insight, Sadique et al [11]
suggested the following hypotheses. First, the higher the antici-
pated regret from VAAE, the lower the propensity to demand
vaccination. Secondly, the higher the anticipated regret from
infection if not vaccinated, the higher the propensity to demand
vaccination.
In the case of childhood vaccination, parents act as agents for
their child by weighing up the benefits and the costs from their
decision to vaccinate or not, choosing the option that maximises
their expected utility, or minimises their regret. In doing so,
parents confront trade-offs between the risks that their child faces.
These trade-offs are not confined to the consideration of risk; the
decision to vaccinate is also contingent on other factors, such as
the cost of obtaining vaccination.
Data and Methods
A DCE was used to investigate the influence of risk perceptions,
health impacts, and costs on the stated vaccination choices of
mothers of young children. The study involved respondents being
given a choice between two alternatives – ‘to vaccinate’ and ‘not to
vaccinate’ – without the option to remain undecided between the
two. The DCE method requires the identification of attributes of
the objects of choice, in this case vaccination and non-vaccination,
and the construction of choice scenarios involving different
combinations of different levels of these attributes.
We chose to create choice scenarios about artificial rather than
real vaccines. The reason for this was to avoid any pre-existing
bias and to ensure that we had a wide range of levels for the
attributes. The vaccines are based on real diseases: rotavirus,
a common, but usually mild infection; invasive pneumococcal
disease (IPD), a severe but rare disease; and non-invasive
pneumococcal disease (NIPD), a disease with moderate incidence
and severity. These were selected because of the contrasting nature
of the risks associated with them and because vaccines for these
were being considered for introduction into national immunisation
schedules at the time of the study. The attributes and levels used
were loosely based on the severity and probability of these diseases
and the adverse events that may be associated with the vaccines for
them.
The selection of attributes and their levels was informed by
a review of the literature, which identified key influences on
vaccination decisions. Risk perception is linked to vaccination
behaviours [1,14–17]. Relevant considerations include both the
severity of health effects and the probability that they will be
experienced [14], which led us to included both in our measure of
risk perception. We identified three types of attributes likely to be
important to vaccination choices: the price of the vaccine; the
probability of the occurrence of health problems, and the severity
of health problems. Including the price of the vaccination allows us
to generate estimates of willingness to pay (WTP) for desirable
attributes and willingness to accept (WTA) for undesirable
attributes [18,19]. The inclusion of a cost (or price) attribute in
DCE makes it possible to indirectly obtain the respondent’s WTP
for the attribute. This is one of the advantages of DCE where
WTP estimates are obtained indirectly from the revealed
preferences rather than asking WTP questions directly. However,
the inclusion of a cost attribute, particularly within collectively
funded healthcare systems can be challenging where individuals
are not used to paying for a service or a good at the point of
consumption. Some evidence suggests that the levels of the cost
attribute can affect the estimates [20], but there is no evidence to
suggest that including a cost attribute in a DCE leads to change in
preference compared to that without a cost attribute [21].
Since the decision to vaccinate is modelled as a choice between
vaccinating and not vaccinating, each attribute is divided into two
groups. There are two types of probability of occurrence – the
probability of infection and the probability of VAAE - and two
types of severity of health consequences – the severity of infection,
and severity of VAAE. Similarly, there are costs associated with
a decision to vaccinate, and the cost of infection associated with
a decision not to vaccinate. However, we only included the out-of-
pocket price of vaccination, which is of course zero for the non-
vaccination option. We assume that other relevant perceived costs,
those resulting from the consequences of the choice, are taken into
account in assessing the importance of the levels of severity of
VAAE and infection.
The levels for the probability and severity attributes were
chosen so that their description differed clearly and also broadly
reflected the actual probabilities and severities of the diseases. The
probabilities were generally inflated for the risks of vaccine
associated side effects – otherwise the risks being described would
have been extremely small. For each vaccine, three levels of
severity and probability are presented. These are referred to as
Risk Perception and Demand for Vaccination
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low, medium and high, although the descriptors for these levels
differ between vaccines, reflecting the different characteristics of
each disease. The attributes and levels used are reported in
supporting Table S1.
The combination of three attributes with three levels each
resulted in 27(33) choice sets for each of the two options,
vaccination and non-vaccination. However, a fractional factorial
design method [22] requires 9 choice sets for each option, which
were combined into a single choice – vaccinate or not - using a fold
over design. Because there are three diseases, each respondent
would potentially face 27 different choice sets. A typical choice set
is shown in Figure 1. Respondents were presented with choice sets
and for each were asked their preferred decision.
A pilot study was carried out on a small convenience sample of
mothers (n = 15) to test whether or not respondents could plausibly
complete the DCE questionnaire and provide meaningful
responses, to determine the best ways of expressing the attributes
and to determine the numbers of attributes and levels. The pilot
study enabled us to design the choice experiment so that it
minimised task complexity and helped us to decide how best to
present the probabilities and to frame questions on regret.
However, it was clear from the pilot study that it was not feasible
to ask participants to consider this number of choice sets. We
therefore constructed 3 different versions of the questionnaire,
each of which contained 9 choice sets, 3 for each disease.
Each version of the questionnaire included a further 3 choice
sets, randomly taking one choice set from each disease from the 9
choice sets that were initially presented, to which a question about
regret was included. Each of the 3 initial versions of the
questionnaire therefore has 3 variants, so that there were 9
different versions of the questionnaire. A flow of diagram of
questionnaire allocation is given in Figure 2.
The regret questions assessed the strength of the emotions
mothers anticipated that they might experience if their vaccination
decision had adverse outcomes. On the basis of the attributes and
levels in the corresponding choice set for which respondents had
already indicated their preference, respondents were asked to
indicate how they would experience a particular state of emotion
on a 0–10 scale if their vaccination decision were to turn out badly,
where 0 means I would not experience this at all and 10 means I would
experience this a lot. This scale was based on that used in previous
studies [16,23,24]. Respondents were asked these two questions:
‘‘If you have decided to vaccinate, how likely are you to regret
this decision given that there is some chance that your child may
experience vaccine associated side effects as described above?’’;
and ‘‘If you have decided to not vaccinate, how likely are you to
regret this decision given that there is some chance that your child
may experience disease as described above?’’.
One more choice set was added to every questionnaire in which
the attributes for vaccination are set at the best level and the
attributes for non-vaccination are set at the worst level. This
choice set was included as an extreme case where utility from the
vaccination decision should be maximised and utility from non-
vaccination should be minimised. The intention was to obtain
information on how participants would respond to an extreme
scenario, which might indicate that they have either extreme or
irrational preferences.
Figure 1. Sample choice set.
doi:10.1371/journal.pone.0054149.g001
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To summarise, each respondent was asked to make 13 choices:
3 choice sets for each of the 3 diseases plus 3 choice sets including
regret and one designed to test their choice under circumstances
where vaccination is most likely to be attractive.
Respondents were also asked to evaluate the health states that
appeared in the choice sets. They were first asked to rank the
health states from best to worst. They then gave a rating of the
health states from 0, meaning the worst imaginable health state, to
100, meaning the best imaginable health state, using a Visual
Analogue Scale (VAS) similar to the EuroQol Group’s EQ-VAS
[25]. The choice sets covered 15 different health states, but in
order to minimise respondent burden each respondent were asked
to evaluate only a subset of these health states in their
corresponding questionnaire. Six out of a possible 15 health states
were allocated to different versions of the questionnaire. A copy of
the questionnaire is available on request.
A survey of mothers who had at least one child under the age of
5 years was conducted in January 2007. These were considered to
be the group to whom the survey is most relevant. Approval for the
study was obtained from the City University Research Ethics
Committee. Verbal consent of respondents was obtained. A
detailed explanatory statement was given to respondents de-
scribing the study, which highlighted that their participation was
voluntary and no identifiable personal data would be collected.
The sample was recruited and data were collected by a market
research agency, using a nationally representative sampling frame
across England and boosted in Wales to ensure that we have
proportional regional quotas. Interviews were randomly located
but demographic quotas were set in order to mirror the national
population. A target of at least 35 respondents was set for each of
the 9 versions of the questionnaire.
The data were obtained from interviewer-led completion of
questionnaire. Participants were recruited by the data collecting
agency from convenient locations and were not paid for
participation. Interviewers were given clear instructions on
administering the questionnaire. First, general information was
given about risks and severity of both infectious diseases and their
hypothetical vaccines. This was followed by a description of three
hypothetical vaccines and an explanation of the DCE questions.
Subsequently, respondents were presented with the questionnaire.
The questionnaire contained the 13 choice questions explained
above, as well as questions about the respondent’s knowledge,
awareness and beliefs regarding vaccination against infectious
disease in general, about the sources of information regarding
child vaccination related issues that are known to them, and about
socio-demographic attributes. Their awareness of infectious
disease was measured from their perceptions of the severity of
rotavirus infection. They were also asked if they believe that
‘immunisation weakens a child’s natural immunity’, their response
to this statement was taken as a proxy of their belief about
immunisation.
We used a logistic regression model to analyse the data as the
dependent variable was binary- 1 for vaccination and 0 for no
vaccination. Since respondents have to make several choices, the
data have a panel structure. To account for the potential
correlation between the responses given by each respondent,
a random effects model was applied. The explanatory variables
were the probabilities and severities of VAAE and of infection and
the price of the vaccine. Because the different diseases vary
considerably in terms of their probability and severity, the effects
of such variation may not be adequately captured by the estimated
Figure 2. Flow diagram of questionnaire.
doi:10.1371/journal.pone.0054149.g002
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parameters of risk and attributes. Two dummy variables were
therefore included representing the diseases - NIPD and IPD.
The variable representing the severity of the health states was
the corresponding visual analogue scale (VAS) score given to it by
the respondent, rescaled by subtracting it from 100 so that severity
reflects a decrement from full health, so that 100 is the worst state
possible and 0 the best. As noted earlier, participants were asked to
rate 6 of the 15 states that appear in the choice sets. For the health
states that participants did not rate, the VAS scores were imputed
using the mean imputation method. Mean imputation is the
replacement of a missing observation with the mean of the non-
missing observations for that variable. Although such simple
imputation methods are commonly used in the social sciences
[26,27] they are often not adequate to handle the missing data
problem [28]. The sensitivity of the regression results were
checked using an alternative imputation approach. In the
alternative imputation method missing values were imputed from
the distribution of health state values observed in the non-missing
observations.
Marginal effects of the attributes on the probability of
vaccination were estimated using the Stata program margeff, which
calculates the average marginal effects for each observation and
averages these across all observations. The monetary valuation of
each attribute or price is given by the trade-offs between price and
each attribute that are implicit when respondents make choices
[18,19]. The discrete choice experiment is designed to replicate
partly the decision making process when respondents choose either
to vaccinate or not by making trade-offs between the attributes.
The trade-offs are quantified by dividing each regression co-
efficient by the regression coefficient for price. This gives the
equivalent amount of income respondents are prepared to give up
or accept for a change in the level of another characteristic.
Confidence intervals for the WTP/WTA ratio were calculated
using the Krinsky-Robb method using 2,000 replications [29].
Results
369 participants completed a questionnaire, yielding 4,753
individual choice observations. Table 1 compares the socio-
demographic profile of the sample with that of the relevant UK
population i.e. mothers of children under the age of 5 years. The
sample is slightly over-represented by people from skilled and
unskilled manual worker groups and underrepresented from
supervisory and managerial socioeconomic groups. The sample
is also relatively old and has a lower level of education.
347 respondents (94%) chose vaccination in the choice set
where vaccination was most attractive. 118 respondents (31.9%),
always made the same choice to vaccinate or not to vaccinate
irrespective of the different levels of the attributes, of whom 107
(28.9%) always chose vaccination.
Aggregating the stated choices of all respondents over all choice
sets we find that the vaccination rate for all vaccines together is
77%, with the highest rate (91%) being observed in case of
Invasive-Pneumococcal disease, and the lowest rate (68%)
observed for Rotavirus disease.
Table 2 shows the parameter estimates from the baseline logit
model. The Likelihood-ratio test shows that it is preferable to use
panel rather than pooled estimates and the Hausman test
(x2(7) = 2.73, p = 0.90) shows that a random rather than fixed
effects model is preferable. The fraction of correctly classified
outcomes (78%) suggests that the model is a reasonable fit to the
data.
The estimated coefficients all have the expected signs, and all
attributes other than the probability of VAAE are significantly
different from zero at the 5% level. Respondents are more likely to
vaccinate their child with a higher probability of disease, a higher
level of disease severity, a lower level of severity of VAAE and
a lower price. Compared with rotavirus, they are also more likely
to vaccinate if the disease is NIPD and even more so if the disease
is IPD.
Table 3 shows the estimates from the extended model, in which
the effect of regret is included. Both regret variables are significant,
with the theoretically expected sign. In general, respondents
anticipate much higher regret from a decision not to vaccinate
than to vaccinate. We can estimate what might be called ‘regret
elasticities of demand’; if anticipated regret from deciding to
vaccinate increases by one unit, then the propensity to vaccinate
decreases by 2.8%, whilst a one unit change in regret from
deciding not to vaccinate increases the probability of a child being
vaccinated by 5.9%. In the extended model, the severity of health
effects associated with infection and VAAE both exert a statistically
significant effect on demand, with the expected signs, but the
probabilities of both infection and VAAE fail to achieve statistical
significance.
Table 4 shows estimates of WTP and WTA derived from the
baseline model. Those with a positive coefficient are WTP, those
with a negative coefficient are WTA. We have also checked WTP/
WTA estimates where the alternative to mean imputation was
applied to health states that participants did not rate The
regression coefficients are reported in Table 5. The estimated
coefficients are sensitive to the imputation method, and leads to
a statistically insignificant price coefficient and therefore WTP
estimates are also insignificant. Sensitiveness of estimates to the
alternative imputation method led us to choose the mean
imputation over the distributional imputation method.
Table 6 shows estimates of WTP/WTA values according to
different socio-demographic variables. The socioeconomic status
of households was categorized in two groups – supervisory and
managerial households are combined in one group representing
higher socioeconomic status, and households that have skilled and
unskilled manual workers are combined in another group
representing lower socioeconomic status. Lower income and
socioeconomic status mothers have a relatively high WTP to
avoid disease but a higher WTA to accept severe VAAE.
Education and ethnicity of mothers had no influence on WTP/
WTA.
Mothers’ awareness is proxied by their perceptions of the
severity of rotavirus infection. Mothers’ awareness is categorised
into two – very serious and fairly serious has been grouped as high
awareness and the low awareness group includes perceived
severity of serious, not very serious and not at all serious. Mothers
who perceive rotavirus infection to be serious (i.e., higher
awareness) have a relatively high WTA for VAAE. Similarly,
mothers with a higher awareness of the risk of infectious disease
are willing to pay more to avoid the disease. Mothers who
disagreed with the statement that ‘immunisation weakens a child’s
natural immunity’ had a higher WTP to avoid the disease and
higher WTA for the VAAE.
Table 7 shows the probability of vaccination predicted from the
baseline regression model at different levels of attributes. Price and
probability attributes had 3 discrete levels, but health severity is
measured on a continuous scale (0–100 scale). For ease of
reporting, we have grouped the severity of the health variable into
3 different arbitrary levels: low if the severity of the health state is
,40, medium if the severity of the health state is greater than 40
but less than 70, and high if the severity of the health state is above
70.
Risk Perception and Demand for Vaccination
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These predicted values show that the demand for vaccination
increases with the severity of disease, and is negatively related to
the severity of VAAE. The price of vaccine has a negative
influence on vaccine uptake, but the effect of cost is not
monotonically decreasing in some price ranges. The predicted
probability of vaccination is highest against IPD when the vaccine
has low severity VAAE, and the lowest probable uptake arises for
NIPD when vaccine leads to high severity VAAE. Overall, the
predicted probabilities are higher for vaccination against IPD,
followed by NIPD and rotavirus.
Discussion
Our results demonstrate that the perceived severity of the
disease and the perceived severity of VAAEs influence mothers’
decision making about vaccination of their children. Socioeco-
nomic status, income, and awareness and beliefs regarding
vaccination were all found to be important influences on the
choice of whether or not to vaccinate. These findings add to other
research into attitudes towards immunisation [1,15,17,34].
Our results suggest that anticipated regret is also an important
determinant of choices about vaccination. This adds to the
findings of Connolly and Reb [24], who showed a correlation
between regret and the decision to vaccinate. Similarly, Gallagher
and Povey [15], in exploring the effect of anticipated regret on the
intention to vaccinate against influenza, found that emotional
feelings significantly increased the intention to vaccinate. Specif-
ically, the influence of regret appears to be asymmetric – decisions
are more sensitive to ex ante regrets about not vaccinating than they
are to regrets about vaccinating. We have no information about
why this is so, but one possible reason is that the dominant societal
point of view, reinforced by pro-vaccination messages from health
professionals, is that vaccination should be the norm. Regret
derived from the negative consequences of deviating from a norm
may be much greater than that from adhering to one.
The results show that anticipated regrets are strong predictors of
vaccination. The severities of health associated with both diseases
and VAAEs are significant predictors of vaccination even when
regret variables are included. But the coefficient for the probability
of disease and VAAE were reduced and became statistically
insignificant when regret variables are included (compared with
the base case model). Anticipated regrets may have mediated the
Table 1. Characteristics of respondents and corresponding population statistics.
Sample
(N=369) Population
Sample
(N=369) Population
Age * Education ***
under 20 4.1% 6.8% Degree or equivalent 13.6% 26.30%
20–29 42.2% 44.9% Higher education below degree 14.4% 15.19%
30–39 43.2% 44.8% A level equivalent 14.6% 15.19%
40 and over 10.5% 3.5% GCSE/O level equivalent 37.4% 24.72%
Missing 0.8% – CSE other grade equivalent 4.6% 8.39%
Region ** None 14.9% 7.71%
North East 5.6% 5.7% Missing 0.5% –
North West 16.0% 15.3% Socioeconomic status ****
Yorks 9.1% 11.5% Managerial 19.8% 28.02%
West Midlands 9.1% 12.0% Supervisory/clerical 21.7% 28.70%
London 11.0% 16.7% Skilled manual 21.7% 20.02%
South East 5.6% 9.5% Unskilled manual 34.4% 23.06%
South West 10.0% 11.4% Missing 2.4% -
Wales 22.3% 6.6%
Scotland 11.3% 11.4%
*Office of National Statistics [30];
**Office of National Statistics [31];
***Health Survey for England [32];
****Office of National Statistics [33].
doi:10.1371/journal.pone.0054149.t001
Table 2. Baseline regression model.
Parameter coefficient
Standard
error P.|z|
Marginal
effect
Price 20.003 0.001 0.019 0.000
Probability of VAAE 20.066 0.059 0.265 20.007
Probability of disease 0.002 0.001 0.004 0.000
Severity of VAAE 20.041 0.003 0.000 20.004
Severity of disease 0.023 0.004 0.000 0.003
NIPD 0.603 0.245 0.014 0.082
IPD 1.991 0.286 0.000 0.195
Constant 1.836 0.368 0.000
r (standard error) 0.57 (0.032)
Log Likelihood 21391.31
x2 (p) 581.73 (0.000)
Correct prediction 78.13%
N 3660
VAAE: vaccine associated adverse events; NIPD: non2invasive pneumococcal
disease; IPD: invasive pneumococcal disease.
doi:10.1371/journal.pone.0054149.t002
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relationship between the probability of disease/side effects and
vaccination, but such relationship could not be inferred from the
current findings.
Social gradients with respect to social grade, income, awareness,
and beliefs of mothers influence the decision to vaccinate. The
findings suggest that parents with a high social status are less
willing to pay to avoid the severity of disease, and require less
compensation to accept the severity of vaccine side effects. Similar
effects have been observed with respect to household income.
Intuitively it seems likely to be due to an income effect as parents
with higher social status may shift away to safer vaccines. This kind
of behaviour is observed in the case of measles, mumps and rubella
(MMR) vaccines where parents of higher income group tended to
prefer single doses of private MMR vaccines as opposed to
combined MMR vaccine which had alleged (although unproven)
side effects [35].
The results also show that mothers who have a high
awareness about the risk of infectious diseases require more
compensation to accept vaccine side effects than mothers who
have less awareness. Similarly, mothers with a high awareness of
the risk of infectious diseases are willing to pay more to avoid
the disease compared to mothers with a low awareness. Similar
results are observed with respect to mothers’ belief about
immunisation. Mothers who disagree with the statement that
‘immunisation weakens a child’s natural immunity’ have
consistently shown a higher WTP to avoid the disease and
a higher WTA for avoiding vaccine side effects. The reasons
could be that mothers who are more aware of disease are also
Table 3. Extended (Baseline plus Regret) model.
Parameter coefficient Standard error P.|z| Marginal effect
Price 20.002 0.005 0.707 0.000
Probability of VAAE 0.262 0.160 0.102 0.022
Probability of disease 0.002 0.001 0.135 0.000
Severity of VAAE 20.044 0.008 0.000 20.004
Severity of disease 0.028 0.009 0.001 0.002
Anticipated regret vaccination 20.288 0.062 0.000 20.024
Anticipated regret not vaccinated 0.591 0.074 0.000 0.049
NIPD 0.360 0.591 0.548 0.034
IPD 1.466 0.681 0.031 0.120
Constant 21.295 0.998 0.194
r (standard error) 0.66 (0.046)
Log Likelihood 2411.88
x2 (p value) 106.94 (0.000)
Correct prediction 78.61%
N 1093
VAAE: vaccine associated adverse events; NIPD: non-invasive pneumococcal disease;
IPD: invasive pneumococcal disease.
doi:10.1371/journal.pone.0054149.t003
Table 4. Estimates of willingness to pay or willingness to
accept in £.
Parameter WTP/WTA
Upper & lower
Confidence Interval
Probability of VAAE 219.39 2109.49, 15.42
Probability of disease 0.52 0.08, 2.55
Severity of VAAE 212.15 246.71, 26.14
Severity of disease 6.91 3.29, 27.39
NIPD 178.29 15.39, 867.38
IPD 588.44 247.11, 2483.43
VAAE: vaccine associated adverse events; NIPD: non-invasive pneumococcal
disease; IPD: invasive pneumococcal disease; WTP: willingness to pay; WTA:
willingness to accept.
doi:10.1371/journal.pone.0054149.t004
Table 5. Baseline regression results adopting alternative
imputation method.
Parameter coefficient
Standard
error P.|z|
Marginal
effect
Price 20.002 0.001 0.139 0.000
Probability of VAAE 20.077 0.056 0.172 20.009
Probability of disease 0.002 0.001 0.000 0.000
Severity of VAAE 20.025 0.002 0.000 20.003
Severity of disease 0.010 0.002 0.000 0.001
NIPD 0.784 0.233 0.001 0.126
IPD 2.517 0.264 0.000 0.264
Constant 1.446 0.315 0.000
r (standard error) 0.53 (0.033)
Log Likelihood 21469.30
x2 (p) 530.89 (0.000)
Correct prediction 77.67%
N 3660
VAAE: vaccine associated adverse events; NIPD: non-invasive pneumococcal
disease;
PD: invasive pneumococcal disease.
doi:10.1371/journal.pone.0054149.t005
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more responsive to vaccine side effects, but the actual
mechanism of such behaviour could not be explored here.
These findings have implications for both policy and research.
Previous authors have attributed the decline in uptake in
vaccination observed in many developed countries to the decline
in the incidence of disease [36241]. Our findings do not support
this hypothesis, as mothers’ decisions to vaccinate their children do
not appear to be very sensitive to the probability of disease, or
indeed VAAE. Instead, mothers appear to be more sensitive to the
severity of infection and VAAE. This leads to a number of
implications. First, declines in vaccine coverage should be more
strongly associated with a change in the perceived severity of
VAAE, as happens with a vaccine scare, than with declines in
disease incidence. Secondly, public health messages should put
corresponding emphasis on severity to enable people to make
better choices in accordance with their preferences. Thirdly,
studies of decisions to vaccinate should take the perceived severity
of the health states into account.
In addition, anticipated regret appeared to play a significant
role in mothers’ decision-making. Perhaps the asymmetry in
‘regret elasticities’, which suggest that demand is more sensitive to
anticipated regret from the child acquiring the disease than
VAAEs, has helped to keep vaccine coverage relatively high,
despite steep declines in disease incidence. Further research in this
area appears warranted.
The success of vaccination programmes relies as much on the
willing and active participation of mothers as it does on the
availability of safe and effective vaccines. A greater focus on the
factors affecting the demand for vaccines may bring significant
pay-offs in terms of improved population health as well as the
efficiency and equity of these large-scale programmes.
Table 6. Estimates of willingness to pay or willingness to accept (in £) by different socio-demographic characteristics.
Vaccine
probability
Disease
probability
Vaccine
severity
Disease
severity NIPD IPD
Socioeconomic status
Supervisory & managerial 21.94 0.47 211.15 6.52 81.84 466.67
Skilled & unskilled manual worker 260.33 0.73 214.26 8.59 314.12 773.37
Perceived disease severity
Low 250.45 0.82 214.63 9.08 323.60 847.98
High 14.97 0.23 210.31 4.78 25.13 335.17
Income
,£25,000 240.21 1.35 235.94 19.02 296.94 1614.97
.£25,000 15.11 0.51 210.53 5.49 131.77 504.29
Education
A level & above 25.40 0.55 212.46 6.88 155.82 578.53
GCSE or below 231.69 0.51 212.15 7.05 207.46 617.78
Ethnicity
Non-white 210.23 20.58 7.17 27.07 131.18 5.43
White 216.83 0.46 211.21 6.42 171.54 557.76
Immunisation weakens immunity
Disagree 223.94 0.47 215.36 8.05 154.02 616.43
Agree 4.42 0.16 22.66 5.31 70.95 150.03
NIPD: non-invasive pneumococcal disease; IPD: invasive pneumococcal disease.
doi:10.1371/journal.pone.0054149.t006
Table 7. Predicted probability of vaccination at different
levels of attributes.
Rotavirus NIPD IPD
Cost of vaccine
Low 0.87 0.84 0.98
Medium 0.75 0.78 0.97
High 0.76 0.81 0.97
Probability of VAAE
Low 0.76 0.83 0.98
Medium 0.78 0.81 0.97
High 0.85 0.79 0.97
Probability of disease
Low 0.70 0.81 0.97
Medium 0.78 0.80 0.97
High 0.88 0.82 0.98
Severity of VAAE
Low 0.91 0.89 0.99
Medium 0.56 0.67 0.95
High 0.45 0.41 0.81
Severity of disease
Low 0.59 0.69 0.80
Medium 0.81 0.85 0.95
High 0.88 0.94 0.98
VAAE: vaccine associated adverse events; NIPD: non-invasive pneumococcal
disease;
IPD: invasive pneumococcal disease.
doi:10.1371/journal.pone.0054149.t007
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